Finasteride (Compound)

Synonyms:finasteride, 98319-26-7, Proscar, Propecia, Finastid, Prostide, Chibro-Proscar, MK-906, Finpecia, Finasterida, Finasteridum, MK 906, N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide, (5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide, CHEMBL710, NSC-741485, 57GNO57U7G, CHEBI:5062, (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(tert-butyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-tert-butyl-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide, DTXSID3020625, NSC-759318, Finasteridum [INN-Latin], Finasterida [INN-Spanish], (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-dimethylethyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide, DTXCID50625, N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-en-17beta-carboxamide, Andozac, 4-Azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5alpha,17beta)-, Propecia (TN), SMR000466304, Proscar (TN), MK 0906, MK-0906, CCRIS 7438, HSDB 6793, MK906, SR-01000759414, BRN 4269024, UNII-57GNO57U7G, L-652,931, 17beta-(N-tert-butylcarbamoyl)-4-aza-5 alpha-androst-1-en-3-one, NCGC00016965-01, Finasteride [USAN:USP:INN:BAN], N-(2-Methyl-2-propyl)-3-oxo-4-aza-5-alpha-androst-1-ene-17-beta-carboxamide, CAS-98319-26-7, MFCD00869737, YM-152, KS-1058, Finasteride (Proscar), FINASTERIDE [MI], Prestwick0_000717, Prestwick1_000717, Prestwick2_000717, Prestwick3_000717, FINASTERIDE [INN], FINASTERIDE [JAN], FINASTERIDE [USAN], FINASTERIDE [VANDF], SCHEMBL5509, FINASTERIDE [MART.], BSPBio_000933, FINASTERIDE [WHO-DD], MLS000759404, MLS001165768, MLS001424046, Finasteride (JAN/USP/INN), SPBio_002854, BPBio1_001027, GTPL6818, FINASTERIDE [EP IMPURITY], FINASTERIDE [ORANGE BOOK], 4-Azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5.alpha.,17.beta.)-, BCPP000229, FINASTERIDE [EP MONOGRAPH], FINASTERIDE [USP IMPURITY], HMS1570O15, HMS2051F09, HMS2090G22, HMS2097O15, HMS2235L23, HMS3714O15, FINASTERIDE [USP MONOGRAPH], 4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide, ACT02599, ENTADFI COMPONENT FINASTERIDE, EX-A1951, Tox21_110717, Tox21_201506, Tox21_302744, BDBM50334788, NSC741485, NSC757443, s1197, AKOS015894916, Tox21_110717_1, BCP9000685, CCG-100937, CS-1767, DB01216, FINASTERIDE COMPONENT OF ENTADFI, Finasteride, >=98% (HPLC), powder, NC00187, NSC 741485, NSC 759318, NSC-757443, NCGC00093560-05, NCGC00256334-01, NCGC00259057-01, 140375-21-9, BF164456, CPD000466304, HY-13635, BCP0726000222, AB00513901, D00321, AB00513901-07, AB00513901-08, AB00513901_09, Finasteride, VETRANAL(TM), analytical standard, A845840, Q424167, SR-01000759414-4, SR-01000759414-6, BRD-K01095011-001-03-5, BRD-K01095011-001-15-9, Z1501475008, Finasteride, British Pharmacopoeia (BP) Reference Standard, Finasteride, European Pharmacopoeia (EP) Reference Standard, ([1-PHENYL-METH-(E)-YLIDENE]-AMINO)-ACETICACIDETHYLESTER, (17beta-(N-tert-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one, Finasteride, United States Pharmacopeia (USP) Reference Standard, (5?,17?)-N-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide, 4-Azaandrost-1-ene-17-carboxamide,1-dimethylethyl)-3-oxo-, (5.alpha., 17.beta.)-, Finasteride for peak identification, European Pharmacopoeia (EP) Reference Standard, (1S,2R,7R,10S,11S,14S,15S)-N-tert-butyl-2,15-dimethyl-5-oxo-6-azatetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-3-ene-14-carboxamide, (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-isobutyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide, (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-isobutyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide;Finasteride, (4AR,4BS,6AS,7S,9AS,9BS,11AR)-4A,6A-DIMETHYL-2-OXO-2,4A,4B,5,6,6A,7,8,9,9A,9B,10,11,11A-TETRADECAHYDRO-1H-INDENO[5,4-F]QUINOLINE-7-CARBOXYLIC ACID TERT-BUTYLAMIDE, (4aR,4bS,6aS,9aS,9bS,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide, (4aR,6aS)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide, (4aR,6aS,11aR)-4a,6a-Dimethyl-2-oxo-hexadecahydro-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide, (4aR,6aS,7S)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide, (4aR,6aS,7S,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide, (R)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide, 1H-Indeno[5,4-f]quinoline-7-carboxamide, N-(1,1-dimethylethyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-, 4a,6a,9a-Trimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid (Finasteride), 4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide(Finasteride)

Pubchem:PUBCHEM:57363

Id:1e3004da-ce72-5877-922a-e4cfe916b3e3

Description:nan